Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANGIODYNAMICS INCANGO · Entity 5275 | SVP and General Counsel | February 01, 2023 | February 07, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANGIODYNAMICS INC
Report date February 01, 2023 · Filed February 07, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,730 |
Reported balance
After 2023-02-01 transaction · row 1
1 source rowRow 1 · 2023-02-01 · Tax withholding · Disposed 1,137 · Balance 15,730 F1: The exempt disposition of 1,137 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 1, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The exempt disposition of 1,137 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 1, 2021.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DENTSPLY SIRONA Inc.
Report date October 10, 2025 · Filed October 15, 2025
Section 16 reporting ended · disclosed 2025-10-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 85,183.54 |
Reported balance
After 2025-10-10 transaction · row 1
1 source rowRow 1 · 2025-10-10 · Grant · Acquired 766.323 · Balance 85,183.54 F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. |
| Phantom Stock (Supplemental Executive Retirement Plan) SERPSEC Table II · derivative / convertible security | Direct | 6,142.9981 |
Reported balance
After 2025-10-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-10-10 · Grant · Acquired 80.9848 · Balance 6,142.9981 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3: Comprised of phantom stock acquired as a result of accrued dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.
F3: Comprised of phantom stock acquired as a result of accrued dividends.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 10, 2025 Filed Oct 15, 2025 20:52 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative | 80.9848 | $11.98 | $970.20 |
DisclosureSEC source: 0000818479-25-000216 · form4.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,142.9981 Underlying: Common Stock · 80.9848 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 20:52 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 766.323 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000216 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,183.54 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 20:53 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative | 59.2766 | $16.20 | $960.28 |
DisclosureSEC source: 0000818479-25-000132 · form4.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,062.0133 Underlying: Common Stock · 59.2766 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F4 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F3 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 20:53 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 595.34 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000132 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,417.217 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F2 · balance_after: Includes 370 shares acquired between January 1st - June 30, 2025 under the Dentsply Sirona Employee Stock Purchase Plan. Read SEC document |
| April 11, 2025 Filed Apr 15, 2025 20:24 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative | 76.0384 | $12.47 | $948.20 |
DisclosureSEC source: 0001127602-25-012079 · form4.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,002.7367 Underlying: Common Stock · 76.0384 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document |
| April 11, 2025 Filed Apr 15, 2025 20:24 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 628.48 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-012079 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,451.877 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:50 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative | 3,927.023 | $18.98 | $74,534.90 |
DisclosureSEC source: 0001127602-25-010582 · form4.xml · derivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,926.6983 Underlying: Common Stock · 3,927.023 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F2 · shares: Comprised of phantom stock. F3 · price: Supplemental Executive Retirement Plan (SERP) contribution for the year 2024 based on 12/31/24 closing price. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 23:29 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Tax withholdingCommon Stock | 1,440 | $15.59 | $22,449.60 |
DisclosureSEC source: 0001127602-25-008393 · form4.xml · nonDerivative · entry 4 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,823.397 F2 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:29 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 350,100 | $0.00 Strike: $15.99 | $0.00 |
DisclosureSEC source: 0001127602-25-008393 · form4.xml · derivative · entry 5 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,100 Underlying: Common Stock · 350,100 shares Expires 2035-03-03 F3 · derivative.exercise_date: Stock options vest in annual one-third (1/3) increments over a three (3) year period ending March 3, 2028. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:29 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Tax withholdingCommon Stock | 4,956 | $15.99 | $79,246.44 |
DisclosureSEC source: 0001127602-25-008393 · form4.xml · nonDerivative · entry 3 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,263.397 F2 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:29 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Tax withholdingCommon Stock | 1,452 | $15.99 | $23,217.48 |
DisclosureSEC source: 0001127602-25-008393 · form4.xml · nonDerivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,219.397 F2 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:29 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 33,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008393 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,671.397 F1 · shares: Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending 3/3/2028. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:44 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative | 17.1418 | $18.51 | $317.29 |
DisclosureSEC source: 0001127602-25-001225 · form4.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,999.6753 Underlying: Common Stock · 17.1418 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F4 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F3 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:44 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 383.448 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-001225 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,900.397 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F2 · balance_after: Includes 309 shares acquired between July 1st - December 31, 2024 under the Dentsply Sirona Employee Stock Purchase Plan. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:56 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative | 12.8646 | $24.50 | $315.18 |
DisclosureSEC source: 0001127602-24-025513 · form4.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,982.5335 Underlying: Common Stock · 12.8646 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:56 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 266.906 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025513 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,207.949 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 21:07 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative | 12.1397 | $25.80 | $313.20 |
DisclosureSEC source: 0001127602-24-020399 · form4.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,969.6689 Underlying: Common Stock · 12.1397 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F4 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F3 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 21:07 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 287.985 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-020399 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,941.043 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F2 · balance_after: Includes 236 shares acquired between January 1st - June 30,2024 under the Dentsply Sirona Employee Stock Purchase Plan. Read SEC document |
| April 12, 2024 Filed Apr 15, 2024 23:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative | 9.9072 | $31.45 | $311.58 |
DisclosureSEC source: 0001127602-24-012907 · form4.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,957.5292 Underlying: Common Stock · 9.9072 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document |
| April 12, 2024 Filed Apr 15, 2024 23:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 215.105 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012907 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,417.058 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 18, 2024 Filed Mar 19, 2024 21:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative | 1,947.622 | $35.59 | $69,315.87 |
DisclosureSEC source: 0001127602-24-010652 · form4.xml · derivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,947.622 Underlying: Common Stock · 1,947.622 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F2 · shares: Comprised of phantom stock. F3 · price: Supplemental Executive Retirement Plan (SERP) contribution for the year 2023 based on closing price on 12/29/2023. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:28 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 38,900 | $0.00 Strike: $33.28 | $0.00 |
DisclosureSEC source: 0001127602-24-008810 · form4.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,900 Underlying: Common Stock · 38,900 shares Expires 2034-03-04 F2 · derivative.exercise_date: Stock options vest in annual one-third (1/3) increments over a three (3) year period ending March 4, 2027. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:28 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 11,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-008810 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,201.953 F1 · shares: Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending 3/4/2027. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:59 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Tax withholdingCommon Stock | 4,736 | $33.27 | $157,566.72 |
DisclosureSEC source: 0001127602-24-008232 · form4.xml · nonDerivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,557.615 F1 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 22:59 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Tax withholdingCommon Stock | 1,356 | $33.27 | $45,114.12 |
DisclosureSEC source: 0001127602-24-008232 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,293.615 F1 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 19:06 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 193.809 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-001317 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,649.615 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F2 · balance_after: Includes 165 shares acquired between July 1st - December 31, 2023 under the Dentsply Sirona Employee Stock Purchase Plan. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 21:07 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 201.097 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025917 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,290.806 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 21:20 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 171.053 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-020837 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,089.709 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:08 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 173.656 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013150 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,918.656 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:02 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 30,800 | $0.00 Strike: $38.74 | $0.00 |
DisclosureSEC source: 0001127602-23-009260 · form4.xml · derivative · entry 3 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,800 Underlying: Common Stock · 30,800 shares Expires 2023-03-03 F2 · derivative.exercise_date: Stock Options vest in annual one-third (1/3) increments over a three (3) year period ending March 3, 2026. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:02 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 38,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009260 · form4.xml · nonDerivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,745 F1 · kind: Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending March 3, 2026. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:02 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 10,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009260 · form4.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,025 F1 · kind: Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending March 3, 2026. Read SEC document |
| February 01, 2023 Filed Feb 7, 2023 16:00 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 1,137 | $13.36 | $15,190.32 |
DisclosureSEC source: 0001567619-23-002003 · doc1.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,730 F1 · shares: The exempt disposition of 1,137 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 1, 2021. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 18:34 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 9,283 | $0.00 Strike: $21.53 | $0.00 |
DisclosureSEC source: 0001567619-22-014369 · doc1.xml · derivative · entry 3 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,283 Underlying: Common Stock · 9,283 shares Expires 2032-07-20 F3 · derivative.exercise_date: These stock options vest in four equal annual installments beginning on July 20, 2023, such that 25% of the options will vest on each of July 20, 2023, 2024, 2025 and 2026. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 18:34 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantPerformance Right · Derivative | 7,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014369 · doc1.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,925 Underlying: Common Stock · 7,925 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 18:34 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 3,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014369 · doc1.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,867 F1 · shares: The acquisition of 3,963 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 3,963 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 20, 2023, such that 25% of the restricted stock units will vest on each of July 20, 2023, 2024, 2025 and 2026. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 16:14 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 1,194 | $21.31 | $25,444.14 |
DisclosureSEC source: 0001567619-22-002444 · doc1.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,904 F1 · shares: The exempt disposition of 1,194 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 1, 2021. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 18:39 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 8,418 | $0.00 Strike: $10.27 | $0.00 |
DisclosureSEC source: 0001567619-21-013914 · doc1.xml · derivative · entry 3 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,418 Underlying: Common Stock · 8,418 shares Expires 2031-07-21 F3 · derivative.exercise_date: These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 18:39 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantPerformance Right · Derivative | 6,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-013914 · doc1.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,197 Underlying: Common Stock · 6,197 shares Expires not disclosed F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 18:39 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 3,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-013914 · doc1.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,098 F1 · shares: The acquisition of 3,098 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company") represents 3,098 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 21, 2022, such that 25% of the restricted stock units will vest on each of July 21, 2022, 2023, 2024 and 2025. Read SEC document |
| July 21, 2021 Filed Dec 30, 2021 17:53 UTC Amendment | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 8,418 | $0.00 Strike: $26.49 | $0.00 |
DisclosureSEC source: 0001567619-21-022705 · doc1.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,418 Underlying: Common Stock · 8,418 shares Expires 2031-07-21 F1 · security: On July 23, 2021, the reporting person filed a Form 4 to report, among other items, the granting of performance rights and stock options of AngioDynamics, Inc. (the "Company"), which contained administrative errors as to the terms of the performance rights and the exercise price of the options. F3 · derivative.exercise_date: These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025. Read SEC document |
| July 21, 2021 Filed Dec 30, 2021 17:53 UTC Amendment | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantPeformance Right · Derivative | 6,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-022705 · doc1.xml · derivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,197 Underlying: Common Stock · 6,197 shares Expires not disclosed F1 · security: On July 23, 2021, the reporting person filed a Form 4 to report, among other items, the granting of performance rights and stock options of AngioDynamics, Inc. (the "Company"), which contained administrative errors as to the terms of the performance rights and the exercise price of the options. F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of the Company ("Common Stock"). The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of common stock of the Company ("Common Stock"). The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of common stock of the Company ("Common Stock"). The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 20:44 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 62,000 | $0.00 Strike: $18.92 | $0.00 |
DisclosureSEC source: 0001567619-21-002156 · doc1.xml · derivative · entry 2 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2031-02-01 F2 · derivative.exercise_date: These stock options vest in four equal annual installments beginning on February 1, 2022, such that 25% of the options will vest on each of February 1, 2022, 2023, 2024 and 2025. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 20:44 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-002156 · doc1.xml · nonDerivative · entry 1 ROSENZWEIG RICHARD C · CIK 0001206725 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 F1 · shares: The acquisition of 11,000 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 11,000 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on February 1, 2022, such that 25% of the restricted stock units will vest on each of February 1, 2022, 2023, 2024 and 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.